Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02316782 · ClinicalTrials.gov registry record
Bifurcation Lesion Analysis and STenting / BLAST
A clinical trial, sponsored by Volcano Corporation.
- Completed
- Registry status
- 195
- Enrollment target
NCT02316782 is a clinical trial that has completed, run by Volcano Corporation. The registered enrollment target is 195 participants.
The verdict
NCT02316782 has completed, sponsored by Volcano Corporation.
- COMPLETED
- Registry status
- 195 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if Intravascular Ultrasound (IVUS) grayscale and VH (Virtual Histology)-IVUS pre-stenting can assess more accurately the location, amount, and type of a blockage than angiogram alone. Additionally, this study is to determine if IVUS grayscale and VH-IVUS guidance will result in improved acute and long term procedural outcome vs. bifurcation stenting with only angiographic guidance in native coronary arteries.
Interventions
- DEVICE Blinded IVUS assessment
- DEVICE Nonblinded IVUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2008-10 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02316782
The ClinicalTrials.gov registry entry for NCT02316782 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Volcano Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blinded IVUS assessment is the first listed.
NCT02316782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02316782 about?
NCT02316782 is a clinical study titled "Bifurcation Lesion Analysis and STenting / BLAST". The purpose of this research study is to determine if Intravascular Ultrasound (IVUS) grayscale and VH (Virtual Histology)-IVUS pre-stenting can assess more accurately the location, amount, and type of a blockage than angiogram alone. Additionally, this study is to determine if IVUS grayscale and VH...
What is the current status of trial NCT02316782?
This trial is currently completed. The enrollment target is 195 participants. The study started on 2008-10. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02316782?
The interventions under investigation include: Blinded IVUS assessment (DEVICE), Nonblinded IVUS (DEVICE).
Who is sponsoring clinical trial NCT02316782?
This trial is sponsored by Volcano Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.